文献速递乳腺癌放疗

未行乳房切除术后放疗乳腺癌患者的局部区域复发模式

Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy.
PubMed 文献 · Radiat Oncol · 2020-09-04

该回顾性研究纳入7073例未接受乳房切除术后放疗的乳腺癌女性,按风险分层分析局部区域复发分布。中位随访63.0个月,5年局部复发率2.5%、区域复发率4.4%;胸壁和锁骨上/下淋巴结是最常见复发部位,且不受分期或分子亚型影响。年龄、肿瘤位置、T分期、N分期和激素受体状态为局部和区域复发的独立预后因素。

要点

  • 胸壁和锁骨上/下淋巴结是未放疗乳腺癌患者最常见的局部区域复发部位。
  • 5年局部复发率2.5%,区域复发率4.4%。
  • 局部和区域复发的独立预后因素相似,均包括年龄、肿瘤位置、T/N分期和激素受体状态。

核心结论

  • 胸壁和锁骨上/下淋巴结是乳腺癌局部区域复发的常见部位,与疾病分期或分子亚型无关。
  • 局部复发和区域复发的预后因素相似,乳房切除术后放疗应始终考虑照射胸壁和锁骨上/下淋巴结。

研究设计与样本

  • 回顾性研究纳入7073例未接受乳房切除术后放疗的乳腺癌女性。
  • 低风险组4604例(65.1%)为pT1-2 N0,中风险组2042例(28.9%)为pT1-2 N1,高风险组427例(6.0%)为pT3-4和/或pN2-3或新辅助化疗后pT1-2 N1。
  • 采用Kaplan-Meier法估计局部和区域复发率,log-rank检验比较差异,Cox回归进行多因素分析。

主要发现

  • 中位随访63.0个月,469例患者出现局部区域复发。
  • 复发部位分布:胸壁238例(50.7%),锁骨上/下淋巴结236例(50.3%),腋窝92例(19.6%),内乳淋巴结50例(10.7%)。
  • 5年局部复发率为2.5%,区域复发率为4.4%。
  • 三个风险组和五种分子亚型(luminal A、luminal B-Her2阴性、luminal B-Her2阳性、Her2富集型、三阴性)的亚组分析均显示胸壁和锁骨上/下淋巴结是最常见复发部位。
  • 年龄、肿瘤位置、T分期、N分期和激素受体状态是局部复发和区域复发的独立预后因素(p < 0.05)。

临床怎么用

  • 乳房切除术后放疗计划中应始终考虑照射胸壁和锁骨上/下淋巴结。
  • 无论疾病分期或分子亚型,胸壁和锁骨上/下淋巴结均需作为重点照射区域。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To analyze the patterns of locoregional recurrence in breast cancer patients after mastectomy. METHODS: The retrospective study included 7073 women with breast cancer without post-mastectomy radiotherapy: 4604 (65.1%) had pT1-2 N0 disease (low risk); 2042 (28.9%), pT1-2 N1 (intermediate risk); and 427 (6.0%), pT3-4 and/or pN2-3, or pT1-2 N1 after neoadjuvant chemotherapy (high risk). The distribution of cumulative locoregional recurrence was analyzed. The local recurrence and regional recurrence rates were estimated by the Kaplan-Meier method, and differences were compared with the log-rank test. Multivariate analysis was performed using Cox logistic regression analysis. RESULTS: In the median follow-up of 63.0 months, 469 patients had locoregional recurrence: chest wall recurrence in 238 (50.7%) cases, supraclavicular/infraclavicular nodes in 236 (50.3%) cases, axilla in 92 (19.6%), and internal mammary nodes in 50 (10.7%) cases. The 5-year local recurrence and regional recurrence rates were 2.5 and 4.4%, respectively. Subgroup analysis of the three risk groups and five molecular subtypes (luminal A, luminal B-Her2 negative, luminal B-Her2 positive, Her2-enriched, and triple negative) also showed that the chest wall and supraclavicular/infraclavicular nodes were the most common recurrence sites. Age, tumor location, T stage, N stage, and hormone receptor status were independent prognostic factors for both local recurrence and regional recurrence (p < 0.05). CONCLUSIONS: The chest wall and supraclavicular/infraclavicular nodes are common sites of locoregional recurrence in breast cancer, irrespective of disease stage or molecular subtype, and the prognostic factors for local recurrence and regional recurrence are similar. Therefore, chest wall and supraclavicular/infraclavicular nodes irradiation should always be considered in post-mastectomy radiotherapy.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zhao X, Tang Y, Wang S, et al. Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy. Radiat Oncol. 2020. PMID: 32887640. doi:10.1186/s13014-020-01637-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。